Portal Vein Embolization in Hilar Cholangiocarcinoma
Section snippets
Approach
PVE can be performed by two different approaches: transileocolic and transhepatic.5, 6, 7, 8 The transileocolic approach is performed intraoperatively by introducing a catheter in the ileocolic vein and embolizing all the portal branches to be resected. It is important to embolize all branches to avoid recanalization of the portal vein by portal-portal shunts. Indications for this approach include the preference of the surgical group, the lack of availability of a radiologic team with skills in
Indications
Different factors should be taken into account before PVE is performed.
Complications
As with other hepatic percutaneous procedures, PVE is associated with different complications, such as subcapsular hematoma, hemoperitoneum, pseudoaneurysm, portal vein thrombosis, pneumothorax, and infection. In the largest series (240 patients) describing PVE for the treatment of biliary cancers, Nagino and colleagues33 reported only two major complications: one case of hypersplenism with splenomegaly successfully resected, and one extensive portal and mesenteric vein thrombosis unresected
Outcomes
PVE improves resectability and prevents postoperative hepatic dysfunction in patients with biliary tract cancers whose future liver remnant before extended hepatectomy is expected to be of inadequate size. PVE achieves this improvement without impairing postoperative outcome and survival.
In a recent meta-analysis, Abulkhir and colleagues34 examined 37 publications including 1088 patients who underwent PVE before liver resection for liver tumors. Cholangiocarcinoma was the primary tumor in 430
Summary
The only potentially curative treatment for biliary tract cancer is surgery. Extended right hepatectomy and caudate lobe resection is often performed to achieve a R0 resection. To minimize the risk of postoperative liver dysfunction, in patients with an estimated future liver remnant less than or equal to 20% PVE should be performed. If after PVE the estimated future liver remnant is less than or equal to 20% or the degree of hypertrophy is less than or equal to 5%, liver resection is
References (35)
- et al.
Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care
J Vasc Interv Radiol
(2005) - et al.
Right trisegment portal vein embolization for biliary tract carcinoma: technique and clinical utility
Surgery
(2000) - et al.
Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study
Surgery
(1997) - et al.
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils
J Vasc Interv Radiol
(2005) - et al.
Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis
J Vasc Interv Radiol
(2005) - et al.
Portal embolization relieves persistent jaundice after complete biliary drainage
Surgery
(2001) - et al.
Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations
Surgery
(2000) - et al.
Total and segmental liver volume variations: implications for liver surgery
Surgery
(2004) - et al.
Body surface area and body weight predict total liver volume in Western adults
Liver Transpl
(2002) - et al.
Calculation of child and adult standard liver volume for liver transplantation
Hepatology
(1995)
Le Foie. Etudes anatomiques et chirurgicales
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver
Surg Gynecol Obstet
Preoperative transcatheter embolization of the portal venous branch for patients receiving extended lobectomy due to the bile duct carcinoma
J Jpn Soc Clin Surg
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report
Surgery
Place of portal vein embolization
Preoperative portal vein embolization: an audit of 84 patients
Hepatology
Preoperative portal vein embolization: a Western perspective
Cited by (40)
Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma: A critical review
2024, Hepatobiliary and Pancreatic Diseases InternationalProgress in diagnosis and surgical treatment of perihilar cholangiocarcinoma
2019, Gastroenterologia y HepatologiaPreoperative biliary drainage in hilar cholangiocarcinoma: Systematic review and meta-analysis
2017, European Journal of Surgical OncologyCitation Excerpt :According to the results of this meta-analysis, the routine use of preoperative biliary drainage seem to be unjustified, because of the high risk of infective complications. With regards to the role of PBD in patients who had undergone PVE, there is a consensus about performing liver decompression to improve liver function and FLR hypertrophy.40–42 No recommendations have been reached with regards to the most appropriate drainage method.43
The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review
2017, European Journal of Surgical OncologyCitation Excerpt :In order to increase hypertrophy rate using PVE in patients with small FLR there are two ways: Firstly the embolization of segment IV along with right PVE in patients who require extended right hepatectomy65 and second sequential embolization of the ipsilateral hepatic vein if FLR volume was <40% of TLV at 2–3 weeks following PVE.46 Furthermore, a new surgical technique, has been introduced recently, in order to gain rapid and profound hepatic hypertrophy in cases that the FLR is very small.66
Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma
2016, Journal of the American College of SurgeonsCitation Excerpt :All patients included in the study underwent CT volumetry of the future liver remnant (FLR). When the estimated FLR was considered insufficient, preoperative PVE of the contralateral liver was performed.18-20 Liver resection was scheduled at least 4 weeks after PVE if sufficient hypertrophy was achieved.
Jean-Nicolas Vauthey, MD, is a consultant for Sanofi-aventis and Genentech. Dr. Vauthey received honoraria from sanofi-aventis and Genentech. Drs. Vauthey and Abdalla have received research funding from Sanofi-aventis.